Statement Of Members' Equity

BrightPath Biotherapeutics Co., Ltd. - Filing #7603820

Concept As at
2022-03-31
2021-04-01 to
2022-03-31
As at
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
As at
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
As at
2022-03-31
2021-04-01 to
2022-03-31
As at
2022-03-31
As at
2022-03-31
2021-04-01 to
2022-03-31
As at
2022-03-31
As at
2022-03-31
As at
2021-03-31
As at
2021-03-31
As at
2021-03-31
2020-04-01 to
2021-03-31
As at
2021-03-31
2020-04-01 to
2021-03-31
As at
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
As at
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
As at
2021-03-31
As at
2021-03-31
As at
2020-03-31
As at
2020-03-31
As at
2020-03-31
As at
2020-03-31
As at
2020-03-31
As at
2020-03-31
As at
2020-03-31
As at
2020-03-31
Statement of members' equity
Statement of members' equity
Net assets
6,683,967,000 JPY
-10,875,815,000 JPY
6,700,382,000 JPY
22,940,000 JPY
2,531,475,000 JPY
-10,875,815,000 JPY
6,683,967,000 JPY
2,508,534,000 JPY
26,257,000 JPY
6,459,712,000 JPY
-9,391,623,000 JPY
6,443,296,000 JPY
3,511,385,000 JPY
6,443,296,000 JPY
-9,391,623,000 JPY
3,537,642,000 JPY
57,219,000 JPY
-7,671,989,000 JPY
5,433,211,000 JPY
-7,671,989,000 JPY
5,416,796,000 JPY
5,416,796,000 JPY
3,178,018,000 JPY
3,235,237,000 JPY
Changes during period
Profit (loss)
-1,484,192,000 JPY
-1,484,192,000 JPY
-1,484,192,000 JPY
-1,484,192,000 JPY
-1,719,634,000 JPY
-1,719,634,000 JPY
-1,719,634,000 JPY
-1,719,634,000 JPY
Net changes in items other than shareholders' equity
-3,316,000 JPY
-3,316,000 JPY
-30,961,000 JPY
-30,961,000 JPY
Total changes during period
-1,484,192,000 JPY
240,670,000 JPY
240,670,000 JPY
-1,002,850,000 JPY
-1,006,167,000 JPY
-3,316,000 JPY
-1,484,192,000 JPY
240,670,000 JPY
-30,961,000 JPY
-1,719,634,000 JPY
1,026,500,000 JPY
302,405,000 JPY
-1,719,634,000 JPY
1,026,500,000 JPY
333,366,000 JPY
1,026,500,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.